Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: Clinical presentation of 22 children diagnosed during a 30-year period

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 8, 2010, Pages 1253-1257

  Malm, G ^a   Mansson J E ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Follow up studies; Mucopolysaccharidosis type III; Sweden

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GROUPS BY AGE; HUMAN; LABORATORY TEST; MALE; MENTAL DEFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; SANFILIPPO SYNDROME; SCHOOL CHILD; SWEDEN; WALKING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MUCOPOLYSACCHARIDOSIS III; SIBLINGS; SWEDEN; YOUNG ADULT;

EID: 77954380975     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01800.x     Document Type: Article

References (21)

1. Neufeld EF, Muenzer J, ed. The mucopolysaccharidoses. In : Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic & molecular bases of inherited disease. 8th ed.
2. Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA. Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 2008 31 : 240 252.
3. Ruijter GJ, Valstar MJ, van de Kamp JM, van der Helm RM, Durand S, van Diggelen OP, et al. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands. Mol Genet Metab 2008 93 : 104 111.
4. Meyer A, Kossow K, Gal A, Muhlhausen C, Ullrich K, Braulke T, et al. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 2007 120 : e1255 61.
5. Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, et al. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 2005 28 : 1011 1017.
6. Jansen AC, Cao H, Kaplan P, Silver K, Leonard G, De Meirleir L, et al. Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene. Arch Neurol 2007 64 : 1629 1634.
7. Jones MZ, Alroy J, Rutledge JC, Taylor JW, Alvord EC Jr., Toone J, et al. Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J Neuropathol Exp Neurol 1997 56 : 1158 1167.
8. Wraith JE, Danks DM, Rogers JG. Mild Sanfilippo syndrome: a further cause of hyperactivity and behavioural disturbance. Med J Aust 1987 147 : 450 451.
9. Cleary MA, Wraith JE. Management of mucopolysaccharidosis type III. Arch Dis Child 1993 69 : 403 406.
10. Malm G, Lund AM, Mansson JE, Heiberg A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr 2008 97 : 1577 1581.
11. WHO. Motor Development Study: windows for achievement for six gross motor development milestones. Acta Paediatr (Oslo, Norway:1992), Supplement. 2006 450 : 88 95.
12. Blackwell PB, Baker BM. Estimating communication competence of infants and toddlers. J Pediatr Health Care 2002 16 : 29 35.
13. Krivit W, Peters C, Shapiro EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999 12 : 167 176.
14. Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999 105 : 151 156.
15. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999 281 : 249 254.
16. van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet 1981 20 : 152 160.
17. Meyer A, Kossow K, Gal A, Steglich C, Muhlhausen C, Ullrich K, et al. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Hum Mutat 2008 29 : 770.
18. Moog U, van Mierlo I, van Schrojenstein Lantman-de Valk HM, Spaapen L, Maaskant MA, Curfs LM. Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems? Am J Med Genet 2007 145C : 293 301.
19. Beesley C, Moraitou M, Winchester B, Schulpis K, Dimitriou E, Michelakakis H. Sanfilippo B syndrome: molecular defects in Greek patients. Clin Genet 2004 65 : 143 149.
20. Weber B, Guo XH, Kleijer WJ, van de Kamp JJ, Poorthuis BJ, Hopwood JJ. Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet 1999 7 : 34 44.
21. Yogalingam G, Hopwood JJ. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat 2001 18 : 264 281.